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Abstract
Background: There is an urgent need for epidemiological research in primary care to develop risk 
assessment processes for patients presenting with COVID-19, but lack of a standardised approach to 
data collection is a significant barrier to implementation.
Aim: To collate a list of relevant symptoms, assessment items, demographics, and lifestyle and health 
conditions associated with COVID-19, and match these data items with corresponding SNOMED CT 
clinical terms to support the development and implementation of consultation templates.
Design & setting: Published and preprint literature for systematic reviews, meta- analyses, and clinical 
guidelines describing the symptoms, assessment items, demographics, and/or lifestyle and health 
conditions associated with COVID-19 and its complications were reviewed. Corresponding clinical 
concepts from SNOMED CT, a widely used structured clinical vocabulary for electronic primary care 
health records, were identified.
Method: Guidelines and published and unpublished reviews (N = 61) were utilised to collate a list 
of relevant data items for COVID-19 consultations. The NHS Digital SNOMED CT Browser was used 
to identify concept and descriptive identifiers. Key implementation challenges were conceptualised 
through a Normalisation Process Theory (NPT) lens.
Results: In total, 32 symptoms, eight demographic and lifestyle features, 25 health conditions, and 
20 assessment items relevant to COVID-19 were identified, with proposed corresponding SNOMED 
CT concepts. These data items can be adapted into a consultation template for COVID-19. Key 
implementation challenges include: 1) engaging with key stakeholders to achieve ’buy in’; and 2) 
ensuring any template is usable within practice settings.
Conclusion: Consultation templates for COVID-19 are needed to standardise data collection, facilitate 
research and learning, and potentially improve quality of care for COVID-19.
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How this fits in
Recording of clinical features of COVID-19 presentation in primary care is likely to be poor in the 
absence of a template. A rapid literature review was therefore conducted to collate a comprehensive 
list of symptoms, assessment items, demographics, and lifestyle and health conditions associated 
with COVID-19, with proposed corresponding SNOMED CT clinical terms. The evidence base around 
COVID-19 is rapidly evolving and this list may have to be updated in the future as new evidence 
becomes available. These data items can be adapted into a consultation template to standardise data 
collection, which in turn can facilitate research and improve quality of record keeping. In practice, 
there are often multiple SNOMED CT clinical terms for recording a single data item. A professional 
consensus will be needed among clinician users to agree on appropriate SNOMED CT clinical terms 
to be used in a template. Implementation and widespread use of a COVID-19 consultation template 
will need positive engagement with key stakeholders.
Introduction
The COVID-19 pandemic is an unprecedented global health challenge. Understanding of the 
epidemiology and clinical features of COVID-19 is rapidly evolving. New evidence is constantly 
emerging, with articles being published or uploaded on preprint servers regularly and various public 
health bodies, nationally and internationally, releasing their respective guidelines.
COVID-19 consultations in primary care are further complicated by contextual factors. In the UK, 
most of the consultations for patients with COVID-19 related symptoms are conducted remotely.1–3 
This usually involves more than one screen being used at the same time, which makes it challenging 
for GPs to accurately recall and record all relevant clinical features during their consultation with 
patients with suspected COVID-19 symptoms. When the consultation is in- person in the surgery, 
personal protective equipment (PPE) restricts normal recording patterns, and this is even worse during 
home visits.
Good quality epidemiological studies are urgently needed to understand COVID-19.4 Most of the 
epidemiological studies until now have been conducted in secondary care.5 There is an urgent need 
for high- quality primary care epidemiological studies for COVID-19. Recently, the use of COVID-19 
specific codes have been recommended but these codes mainly cover process measures and diagnostic 
terms, not clinical presentation features such as symptoms and assessment.6,7 Previous research has 
suggested that only 37% of clinical problems were coded in primary care records.8 Underreporting of 
relevant clinical features for COVID-19 in primary care is likely during COVID-19 related consultations, 
which will be a significant hindrance for high quality primary care research. A computerised, condition- 
specific template has previously been shown to improve the quality of care and recording in primary 
care, and it could be implemented for COVID-19.9
The aim of this study was to collate a list of relevant symptoms, assessment items, demographics, 
and lifestyle and health conditions associated with COVID-19 and its complications, and match these 
data items with proposed examples of corresponding SNOMED CT clinical terms, which will support 
the development and implementation of primary care consultation templates. The clinical utility of 
any template developed based on this work will be to help clinicians record consultations for patients 
presenting with suspected COVID-19 related symptoms in primary care.
Method
The review of clinical terms involved three distinct stages: 1) search of clinical guidelines, and published 
and preprint literature to collate the list of relevant clinical data items for COVID-19 consultation; 2) 
identify examples of corresponding SNOMED CT codes that map to the identified clinical data items; 
and 3) conceptualise implementation challenges through an NPT lens.
Search for clinical data items for COVID-19
The authors searched PubMed, the preprint server medRxiv, and centre for evidence- based medicine 
websites for reviews using ’COVID-19‘ as a keyword on 14 May 2020. The PubMed search resulted 
in 963 articles, while 548 articles were found on preprint server medRxiv. The inclusion criteria 
were systematic reviews and meta- analyses relating to symptoms, sociodemographic and lifestyle 
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factors, past medical history, and assessment of COVID-19 . As the focus was related to primary 
care assessment, reviews relating to blood tests and imaging for COVID-19 were excluded. Twenty- 
one systematic reviews on preprint servers and 24 published systematic reviews from PubMed were 
identified. The authors searched for COVID-19 related guidelines on Public Health England, Health 
Protection Scotland, Public Health Wales, British Medical Journal (BMJ), Royal College of General 
Practitioners (RCGP), National Institute for Health and Care Excellence (NICE), and World Health 
Organization (WHO) websites. Sixteen clinical guidelines were considered for collating the list of 
COVID-19 consultation data items described above.
Search for corresponding clinical terms for COVID-19
SNOMED CT is the most comprehensive structured clinical terminology in use around the world and 
can be used in electronic health records (http://www. snomed. org/ snomed- ct/ why- snomed- ct). This 
international clinical terminology has been implemented across various health and care settings, 
including primary and secondary care. Principles outlined in Data Quality Guidance: Transitioning 
from Read to SNOMED CT by NHS Digital were used for choosing examples of proposed SNOMED 
CT clinical terms.10 First, the authors referred to appropriate SNOMED hierarchies, for example, 
‘disorders’ or ‘situation’ for recording health conditions, and ‘finding’ or ‘observable entity’ for 
recording symptoms and signs. Only SNOMED CT codes that had equivalent Read codes were 
considered, as Read codes are still in use in general practice in Scotland. Codes that were regarded 
as ‘inactive’ and no longer in use were also excluded. SNOMED CT UK edition (version 20200415) 
was interrogated by the NHS Digital web browser to search for terms and identifiers for each of the 
clinical data items identified from the previous step. Additionally, the SNOMED CT code identified 
was matched to the corresponding Read version 2 codes using NHS Digital browser.11
Table 1 Symptoms and assessment items relevant for COVID-19 primary care consultation with 
respective SNOMED CT concept identifiers
Symptoms (with respective SNOMED CT concept 
identifiers)
Primary care assessment (with respective SNOMED 
CT concept identifiers)
1. Date of onset of symptoms SCTID: 520191000000103
2. H/O fever SCTID: 866621000000103 (common)
3. C/O cough SCTID: 272039006 (common)
4. Productive cough SCTID: 28743005 (common)
5. Fatigue- symptom (finding) SCTID: 272060000 
(common)
6. Myalgia/muscle pain SCTID: 68962001 (common)
7. Dyspnoea SCTID: 267036007 (common)
8. Has a sore throat SCTID: 162388002 (common)
9. C/O anosmia SCTID: 272028008 (common)
10. C/O loss of taste sense SCTID: 272041007 (common)
11. Bloodstained sputum SCTID 61281005
12. Chest pain SCTID: 29857009
13. Joint pain SCTID: 57676002
14. C/O shivering SCTID: 161855003
15. Dizziness SCTID: 404640003
16. C/O a headache SCTID: 272027003
17. H/O disturbance of consciousness SCTID: 
91111000000108
18. Convulsion SCTID: 91175000
19. Syncope symptom SCTID: 272030005
20. Nausea SCTID: 4225870071
21. C/O vomiting SCTID: 272044004
22. Loss of appetite SCTID: 79890006
23. Diarrhoea SCTID: 62315008
24. Abdominal pain SCTID: 21522001
25. Gastrointestinal haemorrhage SCTID: 74474003
26. Nasal symptoms SCTID: 249307003
27. Rhinorrhoea SCTID: 64531003
28. C/O nasal congestion SCTID: 272034001
29. Respiratory symptom SCTID: 161920001
30. Red eye SCTID: 703630003
31. C/O a rash SCTID: 162415008
32. Palpitations SCTID: 80313002
1. Rockwood Clinical Frailty Scale SCTID: 445414007
2. Dyspnoea on exertion SCTID: 60845006
3. Breathless at rest (finding) SCTID: 161941007
4. Ability to perform activities of everyday life SCTID: 
284545001
5. Unable to climb stairs SCTID: 165247006
6. Normal fluid intake SCTID: 161843009
7. Not taking fluids (finding) SCTID: 161845002
8. Oliguria SCTID: 83128009
9. Anuria (finding) SCTID: 2472002
10. Unable to stand (finding) SCTID: 161903000
11. C/O cold extremities SCTID: 161996001
12. Blue lips (finding) SCTID: 162743000
13. Mentally alert SCTID: 248234008
14. O/E confused SCTID: 162702000
15. O/E disorientated SCTID: 163608000
Vital Observations (if available)
16. O/E temperature (observable entity) SCTID: 
309646008
17. O/E pulse rate SCTID: 162986007
18. Peripheral oxygen saturation SCTID: 431314004
19. O/E blood pressure reading SCTID: 163020007
20. O/E respiratory rate SCTID: 162913005
C/O= complains of. H/O = history of. O/E = on examination. SCTID = SNOMED CT Identifier
Jani BD et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101125
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Conceptualising implementation of consultation template
GP consultation templates are often viewed as less patient- centred and potentially disruptive to 
communication.12 The majority of existing consultation templates are used for management of long- 
term conditions; however, they have also been used for recording management of acute infections.13 
Widespread adaptation of a template in a short timeframe can provide significant implementation 
challenges. An NPT lens was used to conceptualise these challenges and corresponding key strategies 
to deal with those challenges.14
Results
Clinical data items and SNOMED CT codes
In total, searches identified 32 symptoms associated with COVID-19 presentation from 10 
guidelines,1,3,15–22 13 published reviews,23–35 and 12 preprint reviews.36–47 See Table 1 for the list of 
symptoms and proposed corresponding SNOMED CT codes. The symptoms of COVID-19 were 
heterogenous in nature and included flu- like; respiratory; gastrointestinal; central nervous system; ear, 
nose, and throat; and eye symptoms reported in the literature.
The clinical domain of primary care assessment for COVID-19 had the least number of supporting 
reviews (two preprint reviews)39,48 and the majority of the data items included were on the basis 
of clinical guidelines,1–3,16–20,49,50 which in turn were based on expert opinions (Table  1). The data 
items included for COVID-19 assessment were based on data items validated for general practice 
consultations, but not specifically for COVID-19 (for example, telephone consultation for suspected 
sepsis49 and use of the NEWS2 tool1).
Demographic factors (age, sex, and ethnicity) were reported to be relevant for COVID-19 
susceptibility and complications by two guidelines,15,20 10 published reviews,5,25,26,28,30,33,51–54 and seven 
preprint reviews.37,43,55–59 Lifestyle factors (working, smoking, and body mass index) were reported 
to be relevant for COVID-19 related assessment by two guidelines,15,20 one published review,51 and 
Table 2 Demographic, lifestyle, and existing health conditions relevant for COVID-19 primary care 
consultations
Lifestyle and demographics (with respec-
tive SNOMED CT concept identifiers)
Past medial history (PMH) relevant for COVID-19 primary care 
consultation (with respective SNOMED CT concept identifiers)
1. Agea
2. Sexa
3. Ethnicity/related nationality data 
(observable entity) SCTID: 186034007
4. Health profession SCTID: 223366009
5. Current smoker SCTID: 77176002
6. Ex- smoker SCTID: 8517006
7. Non- smoker SCTID: 8392000
8. Finding of body mass index SCTID: 
301331008
1. High- risk category for developing complication from COVID-19 
infection SCTID: 1300561000000107
2. H/O diabetes mellitus SCTID: 161445009
3. H/O hypertension SCTID: 161501007
4. Ischaemic heart disease SCTID: 414545008
5. H/O heart failure SCTID: 161505003
6. Rheumatic heart disease SCTID: 23685000
7. H/O atrial fibrillation SCTID: 312442005
8. Cardiac arrhythmia SCTID: 698247007
9. Congenital heart disease SCTID: 13213009
10. Pulmonary heart disease SCTID: 274096000
11. H/O asthma SCTID: 161527007
12. History of chronic obstructive pulmonary disease SCTID: 
270473001
13. Pulmonary emphysema SCTID: 87433001
14. H/O bronchiectasis SCTID: 939431000000108
15. Cystic fibrosis SCTID: 190905008
16. Pulmonary fibrosis SCTID: 51615001
17. Chronic kidney disease SCTID: 709044004
18. Chronic liver disease SCTID: 328383001
19. H/O stroke SCTID: 275526006
20. H/O epilepsy SCTID: 161480008
21. H/O dementia SCTID: 161465002
22. Multiple sclerosis SCTID: 24700007
23. Motor neurone disease SCTID: 37340000
24. Patient immunocompromised SCTID: 370388006
25. Pregnant SCTID: 77386006
aInformation on age and sex is usually documented on all electronic primary care records and is not needed in a 
consultation template. H/O = history of. SCTID = SNOMED CT Identifier. 
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seven preprint reviews.37,43,55–57,59,60 Individuals working in the health profession were regarded as high 
risk by one guideline.20 See Table 2 for the list of relevant demographics and lifestyle factors, and 
examples of corresponding SNOMED CT codes (apart from clinical terms for age and sex, which are 
usually recorded in all primary care records).
In total, 25 health conditions were identified with COVID-19 vulnerability and/or complications, 
reported by two guidelines,15,20 16 published reviews5,25–28,30–33,54,61–66 and 10 preprint 
reviews.37,39,42,45,47,57,59,60,67,68 The list of conditions included the ’high- risk‘ or ’extremely vulnerable 
from COVID-19’ criteria based on guidelines issued by Public Health England and Health Protection 
Scotland.69,70 The list included a breadth of conditions ranging from cardiovascular, respiratory, 
immunosuppressed conditions, and previous cancer (see Table 2 for the list of medical conditions and 
the proposed examples of corresponding SNOMED CT codes). The mapping Read version 2 codes 
for the SNOMED CT codes identified are listed in Supplementary file Tables S1-4.
Implementation challenges and solutions
There is an extensive literature regarding barriers and facilitators to digital health implementation.71 
This literature has demonstrated the importance of considering implementation issues whenever 
introducing any new digital health system, including those relating to electronic medical record 
systems.72 While electronic medical record systems are fully integrated within general practice in the 
UK, changes to functionality or uptake and utilisation of new templates within electronic medical record 
systems may not become widespread unless potential barriers or facilitators to use are considered.73 
NPT is a theory of implementation that has been used extensively over the last decade to understand 
how new service innovations, particularly digital health innovations, can become embedded and 
implemented, or not, as part of routine practice.14 It suggests the need to consider issues relating to: 
coherence, how people make sense of a new way of working; cognitive participation, the engagement 
work required to get people to ’buy into‘ adopting a new way of working; collective action, the work 
of operationalising a new digital tool; and reflexive monitoring, the work of appraising, judging, or 
adapting a new digital innovation. There is evidence that considering and addressing such issues at 
the start of any new digital intervention will enhance the likelihood of routine embedding as part of 
normal practice. Table 3 outlines key issues that should be addressed in order to enhance uptake 
and utilisation of any new COVID-19 template. As a proof of concept, a COVID-19 consultation 
Table 3 Key Normalisation Process Theory- informed implementation issues to consider when intro-
ducing a new COVID-19 template
Coherence
Ensuring that potential users are aware of the new 
template and that they understand the rationale for 
trying to promote utilisation with every COVID-19 
patient.
Cognitive participation Engagement with users will be key to ensure they will 
invest time using the template.
Ensuring that the use of the template should assist 
primary care clinicians in recording relevant clinical items 
rather than act as a hindrance or source of additional 
work.
Ensuring users are clear that the items included in the 
template are evidence based and that it is clinically 
worthwhile to record the data items within the template.
Champions within the GP workforce can be valuable to 
promote uptake.
Collective action Any template needs to be easy to navigate and use. 
A template that is too time- consuming to complete is 
unlikely to achieve widespread utilisation. Consequently, 
any template needs to be embedded in the currently 
used electronic medical record system.
Reflexive monitoring Providing feedback to users regarding data collected 
from the template will enable them to see the potential 
benefits and learning that can be gained through use of 
the template. Providing a mechanism to allow iterative 
feedback so that the template can be improved in line 
with user comments would also be important.
Jani BD et al. BJGP Open 2020; DOI: 10.3399/bjgpopen20X101125
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template prototype using data items relevant for symptoms and assessment was developed at a 
practice level in EMIS (Figure 1). Such consultation template prototypes may have to be modified 
after operationalisation, based on user feedback.
Discussion
The authors identified 32 symptoms, 20 assessment items, eight demographic and lifestyle features, 
and 25 health conditions relevant for recording in COVID-19 primary care consultations. The 
supporting evidence base for these data items comprised of 16 clinical guidelines, 24 published, and 
21 unpublished systematic reviews. The authors propose examples of corresponding clinical terms 
for all clinical data items from the SNOMED CT browser, which can be used to develop consultation 
templates for different primary care IT system providers. The authors also discuss the likely 
implementation challenges and potential solutions for large scale roll out of a COVID-19 consultation 
template. The contents of any COVID-19 consultation template may have to be adapted in future as 
knowledge and understanding evolves.
Strengths and limitations
This is the first study to collate a list of relevant clinical items and corresponding clinical terms for 
COVID-19 consultation. The search for preprint servers enabled the authors to include the most up- 
to- date evidence, with the caveat that these platforms publish rapid non- peer reviewed literature. 
This study also outlines an implementation blueprint using a well- known theoretical framework for 
complex interventions.
There are several limitations. First, the authors did not employ a systematic search strategy for the 
literature review, and did not conduct a quality appraisal of the included studies as these were not the 
objectives of this study. The study objective was to facilitate standardised data collection, which in turn 
can lead to high quality research and strengthen the evidence base. Several data items were included 
Figure 1  A consultation template prototype in EMIS with symptoms and assessment items for recording COVID-19 consultations in primary care
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from preprint studies that have not undergone the scrutiny of peer review, and future evidence may 
suggest that recording of these data items is not necessary for risk assessment in primary care.
Comparison with existing literature
Implementation of a COVID-19 consultation template is likely to face similar challenges to those 
observed with implementation of other general practice consultation templates. The previous positive 
experiences with the use of a template have included providing a structured consultation and being 
more comprehensive, while the use of a template has also been perceived as less patient- centred 
and more focused on a biomedical agenda.12,74,75 The uptake of a template in clinical practice is not 
likely to be universal; clinicians may need prompting and the template may require reinforcing to 
improve utilisation.13 There have been very few primary care- based studies of COVID-19, and these 
studies have not been able to report on symptoms or assessment due to inconsistencies in recording 
of symptoms in primary care.76,77
Implications for research and practice
The list of clinical terms can lead to the development of COVID-19 consultation templates, which in 
turn will help with standardised data collection and high quality research. A consultation template 
can potentially help with quality of clinical care and record keeping by facilitating comprehensive 
coverage of various clinical domains relevant to COVID-19.78 The use of a consultation template along 
with coding of other process measures included in the recently published ontology79 and SNOMED 
CT codes on COVID-19 released by NHS Digital80 can also help with disease surveillance. Several data 
items related to demographics, lifestyle, and past medical history may already be recorded in patient’s 
existing primary care records. These items are still included in the template as they will be relevant in 
out- of- hours settings where this information may not be readily available. The authors acknowledge 
that the codes presented are only examples for recording the relevant clinical data items. In practice, 
there are often multiple ways of recording a single data item and previous research has suggested 
evidence of considerable heterogeneity in SNOMED CT coding.81,82 A professional consensus exercise 
will be needed among clinician users to agree on appropriate SNOMED CT clinical terms. The use of 
a COVID-19 consultation template has the potential to offer consistency in data collection, albeit with 
some variations in codes used to record clinical data items.
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